Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Multiple Myeloma 15Lymphoma, B-Cell, Marginal Zone 5Neoplasms, Plasma Cell 3Lymphoma 3Recurrence 2Pseudomyxoma Peritonei 1Lung Neoplasms 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia, B-Cell 1Infections 1Helicobacter Infections 1Chemotherapy Effect 1Carcinoma, Ovarian Epithelial 1Carcinoma, Non-Small-Cell Lung 1Cachexia 1Appendiceal Neoplasms 1

Interventions

Megestrol Acetate 4Mirtazapine 2ostarine 1nabiximols 1clazakizumab 1anamorelin 1Sodium Chloride 1Physical Therapy Modalities 1Omacor 1Olanzapine 1Nutrition Assessment 1Megestrol 1Infliximab 1Ibuprofen 1Gemcitabine 1Flurandrenolone 1Fecal Microbiota Transplantation 1Cyproheptadine 1Clarithromycin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Cachexia × Clarithromycin × Clear all
NCT02416570 2016-09-16

Is Clarithromycin a Potential Treatment for Cachexia in People With Lung Cancer?

University of Nottingham

Phase 2 Terminated
1 enrolled
Thoracic

Cachexia, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡